Virtu Financial LLC Pro Qr Therapeutics N.V. Transaction History

Virtu Financial LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 20, 2024	SELL	$1.89 - $2.85 $16,936 - $25,538	-8,961 Reduced 25.67%	25,943 $59,000
Q4 2023 Feb 26, 2024	BUY	$1.15 - $2.21 $40,139 - $77,137	34,904 New	34,904 $69,000
Q1 2023 May 01, 2023	BUY	$1.99 - $3.66 $188,182 - $346,104	94,564 New	94,564 $201,000
Q2 2022 Aug 09, 2022	BUY	$0.56 - $1.0 $34,398 - $61,425	61,425 New	61,425 $48,000
Q3 2021 Nov 12, 2021	SELL	$5.16 - $8.47 $71,636 - $117,589	-13,883 Closed	0 $0
Q2 2021 Sep 17, 2021	BUY	$5.75 - $7.59 $79,827 - $105,371	13,883 New	13,883 $94,000
Q4 2017 Feb 09, 2018	SELL	$2.8 - $4.8 $36,820 - $63,120	-13,150 Closed	0 $0
Q3 2017 Nov 15, 2017	BUY	$4.35 - $6.45 $57,202 - $84,817	13,150	13,150 $0

17.4M

37.7K

21.3K

Ticker PRQR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,362,096
Market Cap $157M
Description
ProQR Therapeutics N.V., a biopharmaceutical company, engages in the discovery and development of RNA-based therapeutics for the treatment of genetic disorders. It primarily develops sepofarsen that is in phase II/III clinical trial illuminate trial for treating leber congenital amaurosis 10 disease; and ultevursen, which is in phase II/III clin...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.